A TI of ~2, meaning that the drug is toxic at twice therapeutic levels, is simply terrible. By comparison, aspirin, which is also classified ... Even though both are drugs from that methylxanthine ...

The promise of the new class is that inhibiting Factor XIa seems ... stroke or stent thrombosis compared to placebo – both given alongside aspirin plus a P2Y12 inhibitor – at one year.

That's all down to the latest ­available evidence: and whether you should take aspirin is a case in point. Until just a couple of months ago, I personally wouldn't take a daily aspirin – nor ...

Aspirin is not only one of the best-documented medicines in the world, but also one of the most frequently used drugs of all times. In addition to its role as an analgesic, aspirin is being ...

The British Doctors' Trial (BDT) was the first large-scale prospective study evaluating aspirin therapy for the primary prevention of cardiovascular events. [22] It was an open-label, randomized ...

Any medication comes with the risk of side effects—but experts reveal specific signs that suggest your medicine is making you ...

Willow bark has similar properties to aspirin and has been used historically for pain relief. It’s available as a supplement in various forms, but it isn’t regulated. The research on its ...

Duggan added, “TTX-MC138 is a first-in-class therapeutic candidate that showed evidence of delivery to metastatic lesions in our Phase 0 clinical trial.” TransCode believes that TTX-MC138 is ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...